Avis De Sécurité sur Euphora and Solarice Rapid Exchange Balloon Dilatation Catheters

Selon Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), ce/cet/cette avis de sécurité concerne un dispositif en/au/aux/à Slovenia qui a été fabriqué par Medtronic Ireland Limited.

Qu'est-ce que c'est?

Les avis de sécurité sont des communications que les fabricants de dispositifs médicaux ou leurs représentants font parvenir en particulier aux travailleurs du secteur médical, mais aussi aux utilisateurs de ces dispositifs. Les avis de sécurité concernent les actions entreprises quant aux dispositifs présents sur le marché et peuvent inclure des rappels et des alertes.

En savoir plus sur les données ici
  • Type d'événement
    Field Safety Notice
  • Date
  • Pays de l'événement
  • Source de l'événement
  • Notes / Alertes
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • Notes supplémentaires dans les données
  • Cause
    This communication is to inform you of a voluntary recall of select lot numbers of the medtronic euphora™ and solarice™ semi-compliant rapid exchange (rx) balloon dilatation catheter due to reports of difficulties in removing the stylette. availability of each of these products will vary by geography. a summary of the model numbers and lot numbers affected by this issue can be found in appendix a of this communication. the medtronic nc solarice™ and nc euphora™ non- compliant rx balloon dilatation catheters are not affected by this issue. the total number of customer reports relating to removal difficulties associated with this generation of medtronic semi-compliant rx catheters represent 0.1% of all affected units manufactured and distributed (since 12 january 2017). medtronic has received one (1) report of patient injury related to this matter. .



  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source